Cancer medicine
The Diamantina Institute for Cancer, Immunology and Metabolic Medicine
From Wikipedia, the free encyclopedia
Jump to: navigation, search
This article is an orphan, as few or no other articles link to it. Please introduce links to this page from other articles related to it.
This article does not cite any references or sources. Please help improve this article by adding citations to reliable sources (ideally, using inline citations). Unsourced material may be challenged and removed. (October 2007)
This article is written like an advertisement. Please help rewrite this article from a neutral point of view. For blatant advertising that would require a fundamental rewrite to become encyclopedic, use {{db-spam}} to mark for speedy deletion.
Diamantina Institute for Cancer, Immunology and Metabolic Medicine was newly created in Apr. 2008 for the University of Queensland, based at the Princess Alexandra Hospital, Brisbane, Australia. The Institute focuses on translational research, which works to produce better outcomes for patient treatment. Nearly 200 researchers and postgraduate students work at the Institute within ten research teams divided into three major programs – immunology, cancer cell biology and metabolism.
Ian Frazer is head of the Institute, which was created by combining the Centre for Immunology and Cancer Research and the Centre for Diabetes and Endocrinology Research. Frazer, an immunologist, is well known for his work on the development of a cervical cancer vaccine, which works by protecting women from Human papillomavirus.
Researchers in the immunology research program, headed by Matt Brown, focus on understanding immune physiology, investigating dendritic cell biology, immunotherapy, and musculoskeletal genetics, in order to design better therapeutics for patients.
The cancer biology research program, headed by Tom Gonda, exploits the biology of cancers to develop new anti-cancer therapies through four research areas – investigating molecular oncogenesis, epithelial pathobiology, molecular virology and cell cycle biology.
Researchers in the molecular oncogenesis group focus on the molecular regulation of cell proliferation and differentiation in normal and malignant cells, in particular on the identification and characterisation of oncogenes. Of particular interest are haemopoietic cells and mammary epithelium, which are involved in leukaemias and breast cancer.
Gonda's previous research involved work on two molecules involved in haemopoiesis – the MYB oncoprotein and the receptor for the cytokine GM-CSF. Unique cell systems were developed that enable researchers to approach important issues in normal and leukaemic haemopoiesis. The group are also looking at the role of the MYB gene in breast cancer.
The metabolic research program, headed by John Prins, focuses on a broad range of metabolic disorders including diabetes, obesity, cell signaling, liver metabolism, bone metabolism, pregnancy-related metabolic disorders and endocrine cancers. Basic research is conducted in hormone signaling, adipose, bone and liver cell function and metabolism. Researchers also conduct clinical research with investigator-driven studies in patients with Type 2 diabetes, obesity, non-alcoholic fatty liver disease and renal disease.
The Diamantina Institute for Cancer, Immunology and Metabolic Medicine Diamantina Institute for Cancer, Immunology and Metabolic Medicine was newly created in Apr. 2008 for the University of Queensland , based …
3 KB (395 words) - 14:51, 20 February 2009
Jerome Horwitz Jerome Horwitz of Barbara Ann Karmanos Cancer Institute and Wayne State University School of Medicine is an American scientist . …
1 KB (195 words) - 16:50, 14 March 2009
Stage In medicine, cancer staging In psychology, developmental stage theories In psychodrama, a location where a social role is performed. …
3 KB (274 words) - 22:05, 28 January 2009
Cancer Cancer (medical term: malignant neoplasm ) is a class of disease s in which a … medicines for cancer have not been rigorously studied or tested. …
117 KB (16748 words) - 01:30, 13 April 2009
Oncology (redirect Cancer care) Oncology is the branch of medicine dealing with tumor s (cancer ). A medical professional who practices oncology is an oncologist. …
14 KB (1892 words) - 06:05, 1 April 2009
Lung cancer staging In medicine , lung cancer staging is the assessment of the degree to which a lung cancer has spread from its original source. …
21 KB (3307 words) - 13:29, 17 March 2009
Gynecologic oncology (redirect Gynecologic cancer) Gynecologic oncology is a specialized field of medicine that focuses on cancer s of the female reproductive system, including ovarian cancer …
1 KB (156 words) - 14:35, 16 March 2009
Squamous cell carcinoma (redirect Ear cancer) In medicine , squamous cell carcinoma (SCC) is a form of cancer of the carcinoma type that may occur in many different organs, …
13 KB (1730 words) - 22:21, 17 March 2009
Doug Altman He is the Founder and Director of Centre for Statistics in Medicine and Cancer Research UK Medical Statistics Group. His varied research …
6 KB (778 words) - 06:22, 6 April 2009
Redox therapy Redox therapy is an unproven form of alternative medicine that aims to treat cancer with redox agent s, usually given through the diet. …
8 KB (1279 words) - 22:59, 16 December 2008
Norspermidine Norspermidine is being researched for its use as an antitumor medicine in cancer treatment. References : Category:Polyamines. author Rodriguez- …
3 KB (360 words) - 21:40, 10 April 2009
Veterinary oncology (section Cancer Statistics) Veterinary oncology is a subspecialty of veterinary medicine that deals with cancer diagnosis and treatment in animals. Cancer Statistics …
2 KB (170 words) - 00:06, 15 December 2008
Alternative medicine The term alternative medicine, as used in the modern Western world , encompasses any … concluded that about 31% of cancer patients use some …
78 KB (10117 words) - 21:13, 12 April 2009
Johnston Laboratories (section Laboratories of Experimental Medicine and Cancer Research) School of Tropical Medicine was partly housed in the laboratories_TOC … Laboratories of Experimental Medicine and Cancer Research …
13 KB (2065 words) - 00:33, 4 January 2009
Insulin potentiation therapy (section Modification of cancer cell metabolism) Insulin potentiation therapy (IPT) is an alternative medicine pharmacologic strategy for the chemotherapy of cancer using insulin and …
22 KB (3215 words) - 19:26, 5 November 2008
Ocular oncology (redirect Eye cancer) Ocular oncology is the branch of medicine dealing with tumors relating to the … Eye cancer can affect all parts of the eye . Eye cancer …
9 KB (1277 words) - 21:13, 26 March 2009
Lorraine Day (section Ten Steps to Fight Cancer) Lorraine Jeanette Day is a practitioner of alternative medicine who claims to have discovered the cause and cure of cancer , as a result …
11 KB (1643 words) - 11:10, 6 April 2009
Performance status In medicine (oncology and other fields), performance status is an attempt to quantify cancer patients' general wellbeing. …
6 KB (782 words) - 07:04, 4 March 2009
William Breitbart leader in the fields of Psychosomatic Medicine , Psycho-oncology , and Palliative Care . … Memorial Sloan-Kettering Cancer Center (New York, …
61 KB (9422 words) - 15:40, 7 January 2009
Whole genome amplification In many fields of research, including preimplantation genetic diagnosis , cancer research or forensic medicine , the scarcity of genomic …
Tuesday, April 14, 2009
Cancer medicine
Cancer medicine
The Diamantina Institute for Cancer, Immunology and Metabolic Medicine
From Wikipedia, the free encyclopedia
Jump to: navigation, search
This article is an orphan, as few or no other articles link to it. Please introduce links to this page from other articles related to it. (February 2009)
This article does not cite any references or sources. Please help improve this article by adding citations to reliable sources (ideally, using inline citations). Unsourced material may be challenged and removed. (October 2007)
This article is written like an advertisement. Please help rewrite this article from a neutral point of view. For blatant advertising that would require a fundamental rewrite to become encyclopedic, use {{db-spam}} to mark for speedy deletion.
Diamantina Institute for Cancer, Immunology and Metabolic Medicine was newly created in Apr. 2008 for the University of Queensland, based at the Princess Alexandra Hospital, Brisbane, Australia. The Institute focuses on translational research, which works to produce better outcomes for patient treatment. Nearly 200 researchers and postgraduate students work at the Institute within ten research teams divided into three major programs – immunology, cancer cell biology and metabolism.
Ian Frazer is head of the Institute, which was created by combining the Centre for Immunology and Cancer Research and the Centre for Diabetes and Endocrinology Research. Frazer, an immunologist, is well known for his work on the development of a cervical cancer vaccine, which works by protecting women from Human papillomavirus.
Researchers in the immunology research program, headed by Matt Brown, focus on understanding immune physiology, investigating dendritic cell biology, immunotherapy, and musculoskeletal genetics, in order to design better therapeutics for patients.
The cancer biology research program, headed by Tom Gonda, exploits the biology of cancers to develop new anti-cancer therapies through four research areas – investigating molecular oncogenesis, epithelial pathobiology, molecular virology and cell cycle biology.
Researchers in the molecular oncogenesis group focus on the molecular regulation of cell proliferation and differentiation in normal and malignant cells, in particular on the identification and characterisation of oncogenes. Of particular interest are haemopoietic cells and mammary epithelium, which are involved in leukaemias and breast cancer.
Gonda's previous research involved work on two molecules involved in haemopoiesis – the MYB oncoprotein and the receptor for the cytokine GM-CSF. Unique cell systems were developed that enable researchers to approach important issues in normal and leukaemic haemopoiesis. The group are also looking at the role of the MYB gene in breast cancer.
The metabolic research program, headed by John Prins, focuses on a broad range of metabolic disorders including diabetes, obesity, cell signaling, liver metabolism, bone metabolism, pregnancy-related metabolic disorders and endocrine cancers. Basic research is conducted in hormone signaling, adipose, bone and liver cell function and metabolism. Researchers also conduct clinical research with investigator-driven studies in patients with Type 2 diabetes, obesity, non-alcoholic fatty liver disease and renal disease.
The Diamantina Institute for Cancer, Immunology and Metabolic Medicine
From Wikipedia, the free encyclopedia
Jump to: navigation, search
This article is an orphan, as few or no other articles link to it. Please introduce links to this page from other articles related to it. (February 2009)
This article does not cite any references or sources. Please help improve this article by adding citations to reliable sources (ideally, using inline citations). Unsourced material may be challenged and removed. (October 2007)
This article is written like an advertisement. Please help rewrite this article from a neutral point of view. For blatant advertising that would require a fundamental rewrite to become encyclopedic, use {{db-spam}} to mark for speedy deletion.
Diamantina Institute for Cancer, Immunology and Metabolic Medicine was newly created in Apr. 2008 for the University of Queensland, based at the Princess Alexandra Hospital, Brisbane, Australia. The Institute focuses on translational research, which works to produce better outcomes for patient treatment. Nearly 200 researchers and postgraduate students work at the Institute within ten research teams divided into three major programs – immunology, cancer cell biology and metabolism.
Ian Frazer is head of the Institute, which was created by combining the Centre for Immunology and Cancer Research and the Centre for Diabetes and Endocrinology Research. Frazer, an immunologist, is well known for his work on the development of a cervical cancer vaccine, which works by protecting women from Human papillomavirus.
Researchers in the immunology research program, headed by Matt Brown, focus on understanding immune physiology, investigating dendritic cell biology, immunotherapy, and musculoskeletal genetics, in order to design better therapeutics for patients.
The cancer biology research program, headed by Tom Gonda, exploits the biology of cancers to develop new anti-cancer therapies through four research areas – investigating molecular oncogenesis, epithelial pathobiology, molecular virology and cell cycle biology.
Researchers in the molecular oncogenesis group focus on the molecular regulation of cell proliferation and differentiation in normal and malignant cells, in particular on the identification and characterisation of oncogenes. Of particular interest are haemopoietic cells and mammary epithelium, which are involved in leukaemias and breast cancer.
Gonda's previous research involved work on two molecules involved in haemopoiesis – the MYB oncoprotein and the receptor for the cytokine GM-CSF. Unique cell systems were developed that enable researchers to approach important issues in normal and leukaemic haemopoiesis. The group are also looking at the role of the MYB gene in breast cancer.
The metabolic research program, headed by John Prins, focuses on a broad range of metabolic disorders including diabetes, obesity, cell signaling, liver metabolism, bone metabolism, pregnancy-related metabolic disorders and endocrine cancers. Basic research is conducted in hormone signaling, adipose, bone and liver cell function and metabolism. Researchers also conduct clinical research with investigator-driven studies in patients with Type 2 diabetes, obesity, non-alcoholic fatty liver disease and renal disease.
Subscribe to:
Posts (Atom)
